Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Boston Scientific (BSX) closed the most recent trading day at $101.64, moving +1.33% from the previous trading session.

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we are going to take a look at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Boston City Councilor Sharon Durkan proposed the idea as a way to promote healthier habits among residents and also raise ...

Boston Scientific Corporation develops ... peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is ...

Beyond technological innovations and effectiveness, a key factor is its cost-reduction approach to its products, enabling greater adoption by the medical community. Boston Scientific has performed ...